These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 23919849)
1. Characteristics of women with nausea and vomiting of pregnancy who chose to continue compassionate use of placebo after a randomised trial. Matok I; Umans J; Feghali MN; Clark S; Caritis S; Miodovnik M; Hankins G; Mattison DR; Nordeng H; Koren G J Obstet Gynaecol; 2013 Aug; 33(6):557-60. PubMed ID: 23919849 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial. Koren G; Clark S; Hankins GD; Caritis SN; Miodovnik M; Umans JG; Mattison DR Am J Obstet Gynecol; 2010 Dec; 203(6):571.e1-7. PubMed ID: 20843504 [TBL] [Abstract][Full Text] [Related]
3. Comparing pyridoxine and doxylamine succinate-pyridoxine HCl for nausea and vomiting of pregnancy: A matched, controlled cohort study. Pope E; Maltepe C; Koren G J Clin Pharmacol; 2015 Jul; 55(7):809-14. PubMed ID: 25663469 [TBL] [Abstract][Full Text] [Related]
4. Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy. Koren G; Clark S; Hankins GD; Caritis SN; Umans JG; Miodovnik M; Mattison DR; Matok I BMC Pregnancy Childbirth; 2016 Nov; 16(1):371. PubMed ID: 27881103 [TBL] [Abstract][Full Text] [Related]
5. Should doxylamine-pyridoxine be used for nausea and vomiting of pregnancy? Persaud N; Chin J; Walker M J Obstet Gynaecol Can; 2014 Apr; 36(4):343-348. PubMed ID: 24798673 [TBL] [Abstract][Full Text] [Related]
6. Studying the antiemetic effect of vitamin B6 for morning sickness: pyridoxine and pyridoxal are prodrugs. Matok I; Clark S; Caritis S; Miodovnik M; Umans JG; Hankins G; Mattison DR; Koren G J Clin Pharmacol; 2014 Dec; 54(12):1429-33. PubMed ID: 25052410 [TBL] [Abstract][Full Text] [Related]
7. 8-Way Randomized Controlled Trial of Doxylamine, Pyridoxine and Dicyclomine for Nausea and Vomiting during Pregnancy: Restoration of Unpublished Information. Zhang R; Persaud N PLoS One; 2017; 12(1):e0167609. PubMed ID: 28052111 [TBL] [Abstract][Full Text] [Related]
8. A new pharmacologic treatment for nausea and vomiting of pregnancy. Fantasia HC Nurs Womens Health; 2014; 18(1):73-77. PubMed ID: 24548499 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of doxylamine-pyridoxine for morning sickness. Koren G; Hankins GD; Clark S; Caritis SN; Miodovnik M; Umans JG; Mattison DR Am J Obstet Gynecol; 2016 May; 214(5):664-6. PubMed ID: 26844757 [No Abstract] [Full Text] [Related]
10. Treating morning sickness in the United States--changes in prescribing are needed. Koren G Am J Obstet Gynecol; 2014 Dec; 211(6):602-6. PubMed ID: 25151184 [TBL] [Abstract][Full Text] [Related]
11. FDA approval of doxylamine-pyridoxine therapy for use in pregnancy. Slaughter SR; Hearns-Stokes R; van der Vlugt T; Joffe HV N Engl J Med; 2014 Mar; 370(12):1081-3. PubMed ID: 24645939 [No Abstract] [Full Text] [Related]
12. Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial. Koren G; Clark S; Hankins GD; Caritis SN; Umans JG; Miodovnik M; Mattison DR; Matok I BMC Pregnancy Childbirth; 2015 Mar; 15():59. PubMed ID: 25884778 [TBL] [Abstract][Full Text] [Related]
13. The pharmacologic management of nausea and vomiting of pregnancy. Niebyl JR; Briggs GG J Fam Pract; 2014 Feb; 63(2 Suppl):S31-7. PubMed ID: 24527483 [TBL] [Abstract][Full Text] [Related]
14. The delayed-release combination of doxylamine and pyridoxine (Diclegis®/Diclectin ®) for the treatment of nausea and vomiting of pregnancy. Madjunkova S; Maltepe C; Koren G Paediatr Drugs; 2014 Jun; 16(3):199-211. PubMed ID: 24574047 [TBL] [Abstract][Full Text] [Related]
16. Doxylamine-pyridoxine for nausea and vomiting of pregnancy randomized placebo controlled trial: Prespecified analyses and reanalysis. Persaud N; Meaney C; El-Emam K; Moineddin R; Thorpe K PLoS One; 2018; 13(1):e0189978. PubMed ID: 29342163 [TBL] [Abstract][Full Text] [Related]
17. Critical appraisal of drug therapy for nausea and vomiting of pregnancy: II. Efficacy and safety of diclectin (doxylamine-B6). Bishai R; Mazzotta P; Atanackovic G; Levichek Z; Pole M; Magee LA; Koren G Can J Clin Pharmacol; 2000; 7(3):138-43. PubMed ID: 11044759 [TBL] [Abstract][Full Text] [Related]
18. Determinants of adherence to delayed-release doxylamine and pyridoxine in patients with nausea and vomiting of pregnancy. Costantine MM; Matok I; Chiossi G; Clark S; Miodovnik M; Umans JG; Caritis S; Hankins GD; Koren G Ther Drug Monit; 2012 Oct; 34(5):569-73. PubMed ID: 22972538 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy and safety of bi-daily combination therapy with pyridoxine and doxylamine for nausea and vomiting of pregnancy. Ashkenazi-Hoffnung L; Merlob P; Stahl B; Klinger G Isr Med Assoc J; 2013 Jan; 15(1):23-6. PubMed ID: 23484234 [TBL] [Abstract][Full Text] [Related]